Jarushka Naidoo: Long-Term Toxicity of Immune Checkpoint Inhibitors
Jarushka Naidoo, Full Professor and Consultant Medical Oncologist at Royal College of Surgeons in Irelan, shared a post by Foundation for Autoimmune Cancer Support (FACS-ASPIRE), on LinkedIn:
“Long-Term Toxicity of Immune Checkpoint Inhibitors JAMA Oncology.
Here, our stellar fellow Chris Cronin charts a roadmap of how to quantitate the nuanced toxicities of IO- from irAEs to time toxicity- towards IO survivorship.”
Authors: Christopher Cronin, Aoife O’Sullivan, Jarushka Naidoo
“Long-Term Toxicity of Immune Checkpoint Inhibitors—Time to Widen the Lens”
Quoting Foundation for Autoimmune Cancer Support‘s post:
“This paper is vital to show the change of cancer treatments and the necessary health care management, novel support, and changes that are needed.
Patients are living! Now let us help patients live the life they want- we need your help to do so, we need to repurpose drugs, clinical trials, education, new approaches to oncology clinics!
We can do this better together.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023